Circio Holding Investor Relations Material

Circio Holding ASA, formerly known as Targovax ASA, is a biotechnology company primarily engaged in the development of innovative circular RNA (circRNA) and immunotherapy medicines. The company has pioneered a distinctive circRNA platform, aiming to create novel circRNA medicines for a variety of applications including rare diseases, vaccines, cancer treatments, protein replacement therapies, and cell therapy. The company is headquartered in Oslo, Norway, and its shares are listed on the Oslo Stock Exchange under the ticker symbol CRNA.